Workflow
Biotech Services
icon
Search documents
Ginkgo Bioworks (DNA) - 2025 Q1 - Earnings Call Presentation
2025-05-07 01:07
Grow with Ginkgo Q1 2025 Update & Business Review May 6, 2025 Property of Ginkgo Bioworks — 1 Q1 2025 UPDATE & BUSINESS REVIEW Disclaimer FORWARD-LOOKING STATEMENTS This presentation, the conference call and webcast contain certain forward-looking statements within the meaning of the federal securities laws, including statements regarding our plans, strategies, including with respect to our current expectations, operations and anticipated results of operations, both business and financial, including the tim ...
Ginkgo Bioworks (DNA) - 2025 Q1 - Earnings Call Transcript
2025-05-06 22:32
Ginkgo Bioworks (DNA) Q1 2025 Earnings Call May 06, 2025 05:30 PM ET Company Participants Daniel Marshall - Senior Manager, Communications & OwnershipJason Kelly - Co-Founder & CEOMark Dmytruk - CFOMichael Ryskin - Managing DirectorElizabeth Koslosky - Global Investment Research Associate Conference Call Participants Mark Massaro - Managing Director - Senior Equity Research AnalystTejas Savant - Executive Director & Senior Healthcare Equity AnalystNone - AnalystMatt Larew - Research Analyst - HealthcareBren ...
Ginkgo Bioworks (DNA) - 2025 Q1 - Earnings Call Transcript
2025-05-06 21:30
Ginkgo Bioworks (DNA) Q1 2025 Earnings Call May 06, 2025 05:30 PM ET Speaker0 Communications and ownership. It's my third year here at Ginkgo. I've spent much of that time working behind the scenes with our investor relations team on these earnings calls, but I'm thrilled to be joining you for the first time live on air. I'm joined by Jason Kelly, our cofounder and CEO, and Mark Demetriuk, our CFO. Thanks as always for joining us. We're looking forward to updating you on our progress. As a reminder, during ...